FDA ends for now use of two monoclonal antibodies, spurring a halt in federal shipments of the covid-19 treatments
FDA,Coronavirus,Antibodies,Public Health
From the Left
AllSides Media Bias Rating: Lean Left
The Food and Drug Administration on Monday took two monoclonal antibody therapies off the list of covid-19 treatments for now, saying the medications should not be used anywhere in the United States because they are ineffective against the dominant omicron variant.
As a result, the Biden administration said it will pause distribution of the therapies, manufactured by Regeneron Pharmaceuticals and Eli Lilly, to the states.
Check for Bias
The AI-powered AllSides Bias Checker instantly reveals the bias of a news article. Tap the button to use.
AllSides Picks
News
Under-reported Stories About Gun Regulations, Trump’s War on Drugs, and Canada’s MAID Program Demand a Closer Look
Malayna J. Bizier
August 24th, 2026
Story of the Week
Dr. Fauci Pleads the Fifth
AllSides Staff
July 30th, 2026
Red Blue Translator
FDA (U.S. Food & Drug Administration)
Red Blue Translator
